Boston BioCom brings together preeminent academic expertise, industry-leading pharmaceutical capabilities, and a highly experienced management team to create value from an extraordinary flow of technology opportunities. Our company was founded in late 2007 by Partners HealthCare System (the parent company of Harvard Medical School affiliates Massachusetts General Hospital and Brigham & Women's Hospital and one of the largest academic biomedical research networks in the world) and an expert team of scientific and commercialization professionals with broad industry backgrounds. Pfizer Inc provided seed capital of $10 million in March 2008. Boston BioCom represents a dynamic commercialization initiative based on a distinctive business model for developing a portfolio of novel life sciences technologies originating from Partners' institutions and Russian research institutions and companies.